RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Giulio Francia to Liver Neoplasms, Experimental

Back to Details
This is a "connection" page, showing publications Giulio Francia has written about Liver Neoplasms, Experimental.
Giulio Francia
Connection Strength
0.094
Liver Neoplasms, Experimental
  1. Tang TC, Man S, Xu P, Francia G, Hashimoto K, Emmenegger U, Kerbel RS. Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy. Neoplasia. 2010 Nov; 12(11):928-40.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support